291 related articles for article (PubMed ID: 22849407)
21. Hsp90 regulates the phosphorylation and activity of serum- and glucocorticoid-regulated kinase-1.
Belova L; Brickley DR; Ky B; Sharma SK; Conzen SD
J Biol Chem; 2008 Jul; 283(27):18821-31. PubMed ID: 18456663
[TBL] [Abstract][Full Text] [Related]
22. Heat shock protein 90 (Hsp90) selectively regulates the stability of KDM4B/JMJD2B histone demethylase.
Ipenberg I; Guttmann-Raviv N; Khoury HP; Kupershmit I; Ayoub N
J Biol Chem; 2013 May; 288(21):14681-7. PubMed ID: 23589305
[TBL] [Abstract][Full Text] [Related]
23. 17-DMCHAG, a new geldanamycin derivative, inhibits prostate cancer cells through Hsp90 inhibition and survivin downregulation.
Wang J; Li Z; Lin Z; Zhao B; Wang Y; Peng R; Wang M; Lu C; Shi G; Shen Y
Cancer Lett; 2015 Jun; 362(1):83-96. PubMed ID: 25813406
[TBL] [Abstract][Full Text] [Related]
24. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
[TBL] [Abstract][Full Text] [Related]
25. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
[TBL] [Abstract][Full Text] [Related]
26. Heat Shock Protein 90 regulates the stability of c-Jun in HEK293 Cells.
Lu C; Chen D; Zhang Z; Fang F; Wu Y; Luo L; Yin Z
Mol Cells; 2007 Oct; 24(2):210-4. PubMed ID: 17978573
[TBL] [Abstract][Full Text] [Related]
27. A cell-based screen for inhibitors of protein folding and degradation.
Boschelli F; Golas JM; Petersen R; Lau V; Chen L; Tkach D; Zhao Q; Fruhling DS; Liu H; Nam C; Arndt KT
Cell Stress Chaperones; 2010 Nov; 15(6):913-27. PubMed ID: 20717760
[TBL] [Abstract][Full Text] [Related]
28. Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis.
Powers MV; Clarke PA; Workman P
Cancer Cell; 2008 Sep; 14(3):250-62. PubMed ID: 18772114
[TBL] [Abstract][Full Text] [Related]
29. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK).
Qing G; Yan P; Xiao G
Cell Res; 2006 Nov; 16(11):895-901. PubMed ID: 17088896
[TBL] [Abstract][Full Text] [Related]
30. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
[TBL] [Abstract][Full Text] [Related]
31. Geldanamycin inhibits tyrosine phosphorylation-dependent NF-kappaB activation.
Crèvecoeur J; Merville MP; Piette J; Gloire G
Biochem Pharmacol; 2008 Jun; 75(11):2183-91. PubMed ID: 18455150
[TBL] [Abstract][Full Text] [Related]
32. AQP2 Abundance is Regulated by the E3-Ligase CHIP Via HSP70.
Centrone M; Ranieri M; Di Mise A; Berlingerio SP; Russo A; Deen PMT; Staub O; Valenti G; Tamma G
Cell Physiol Biochem; 2017; 44(2):515-531. PubMed ID: 29145196
[TBL] [Abstract][Full Text] [Related]
33. The E3 ligase CHIP mediates ubiquitination and degradation of mixed-lineage kinase 3.
Blessing NA; Brockman AL; Chadee DN
Mol Cell Biol; 2014 Aug; 34(16):3132-43. PubMed ID: 24912674
[TBL] [Abstract][Full Text] [Related]
34. Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway.
Kimura T; Uesugi M; Takase K; Miyamoto N; Sawada K
Toxicol Appl Pharmacol; 2017 Aug; 329():282-292. PubMed ID: 28624441
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptors harboring kinase domain mutations associate with the heat shock protein 90 chaperone and are destabilized following exposure to geldanamycins.
Shimamura T; Lowell AM; Engelman JA; Shapiro GI
Cancer Res; 2005 Jul; 65(14):6401-8. PubMed ID: 16024644
[TBL] [Abstract][Full Text] [Related]
36. Regulation of LRRK2 stability by the E3 ubiquitin ligase CHIP.
Ding X; Goldberg MS
PLoS One; 2009 Jun; 4(6):e5949. PubMed ID: 19536328
[TBL] [Abstract][Full Text] [Related]
37. Associations of HSP90 client proteins in human breast cancer.
Shipp C; Watson K; Jones GL
Anticancer Res; 2011 Jun; 31(6):2095-101. PubMed ID: 21737627
[TBL] [Abstract][Full Text] [Related]
38. ErbB2 degradation mediated by the co-chaperone protein CHIP.
Zhou P; Fernandes N; Dodge IL; Reddi AL; Rao N; Safran H; DiPetrillo TA; Wazer DE; Band V; Band H
J Biol Chem; 2003 Apr; 278(16):13829-37. PubMed ID: 12574167
[TBL] [Abstract][Full Text] [Related]
39. Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.
Schulz R; Marchenko ND; Holembowski L; Fingerle-Rowson G; Pesic M; Zender L; Dobbelstein M; Moll UM
J Exp Med; 2012 Feb; 209(2):275-89. PubMed ID: 22271573
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation.
Yun BG; Matts RL
Exp Cell Res; 2005 Jul; 307(1):212-23. PubMed ID: 15922741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]